ATE250418T1 - Tabletten enthaltend eine kombination von glibenclamid und metformin - Google Patents

Tabletten enthaltend eine kombination von glibenclamid und metformin

Info

Publication number
ATE250418T1
ATE250418T1 AT98401781T AT98401781T ATE250418T1 AT E250418 T1 ATE250418 T1 AT E250418T1 AT 98401781 T AT98401781 T AT 98401781T AT 98401781 T AT98401781 T AT 98401781T AT E250418 T1 ATE250418 T1 AT E250418T1
Authority
AT
Austria
Prior art keywords
glibenclamide
metformin
combination
tablets containing
tablets
Prior art date
Application number
AT98401781T
Other languages
German (de)
English (en)
Inventor
Yves Bonhomme
Geoffrey Nicholson
Original Assignee
Merck Sante Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8235441&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE250418(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Sante Sas filed Critical Merck Sante Sas
Application granted granted Critical
Publication of ATE250418T1 publication Critical patent/ATE250418T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98401781T 1998-07-15 1998-07-15 Tabletten enthaltend eine kombination von glibenclamid und metformin ATE250418T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98401781A EP0974356B1 (en) 1998-07-15 1998-07-15 Tablets comprising a combination of metformin and glibenclamide

Publications (1)

Publication Number Publication Date
ATE250418T1 true ATE250418T1 (de) 2003-10-15

Family

ID=8235441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98401781T ATE250418T1 (de) 1998-07-15 1998-07-15 Tabletten enthaltend eine kombination von glibenclamid und metformin

Country Status (27)

Country Link
US (2) US6303146B1 (cg-RX-API-DMAC7.html)
EP (4) EP0974356B1 (cg-RX-API-DMAC7.html)
JP (2) JP2002520371A (cg-RX-API-DMAC7.html)
KR (2) KR20040053177A (cg-RX-API-DMAC7.html)
CN (2) CN1146427C (cg-RX-API-DMAC7.html)
AP (1) AP1450A (cg-RX-API-DMAC7.html)
AR (2) AR013052A1 (cg-RX-API-DMAC7.html)
AT (1) ATE250418T1 (cg-RX-API-DMAC7.html)
AU (2) AU753604B2 (cg-RX-API-DMAC7.html)
BR (1) BR9906600A (cg-RX-API-DMAC7.html)
CA (1) CA2303537C (cg-RX-API-DMAC7.html)
DE (1) DE69818444T2 (cg-RX-API-DMAC7.html)
DK (1) DK0974356T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ2846A1 (cg-RX-API-DMAC7.html)
ES (1) ES2206868T3 (cg-RX-API-DMAC7.html)
ID (1) ID25784A (cg-RX-API-DMAC7.html)
MA (1) MA24930A1 (cg-RX-API-DMAC7.html)
MY (1) MY129552A (cg-RX-API-DMAC7.html)
NZ (1) NZ503248A (cg-RX-API-DMAC7.html)
OA (1) OA11400A (cg-RX-API-DMAC7.html)
PT (1) PT974356E (cg-RX-API-DMAC7.html)
RU (2) RU2226396C2 (cg-RX-API-DMAC7.html)
SI (1) SI0974356T1 (cg-RX-API-DMAC7.html)
TW (2) TWI245632B (cg-RX-API-DMAC7.html)
UY (1) UY25611A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000003742A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200001159B (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
IL149139A0 (en) 1999-11-03 2002-11-10 Bristol Myers Squibb Co Pharmaceutical compositions containing metformin and glyburide
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
FR2816840B1 (fr) 2000-11-17 2004-04-09 Flamel Tech Sa Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
FR2816841B1 (fr) * 2000-11-22 2004-02-06 Lipha Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
PL362687A1 (en) * 2001-01-12 2004-11-02 Sun Pharmaceutical Industries Limited Spaced drug delivery system
FR2825023B1 (fr) * 2001-05-23 2005-04-15 Flamel Tech Sa Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
US20050271737A1 (en) * 2001-06-07 2005-12-08 Chinea Vanessa I Application of a bioactive agent to a substrate
US7767249B2 (en) * 2001-06-07 2010-08-03 Hewlett-Packard Development Company, L.P. Preparation of nanoparticles
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
ATE378054T1 (de) 2001-07-30 2007-11-15 Mitsubishi Pharma Corp Mittel zu linderung von hyperglykämie nach dem essen
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
ITFI20010230A1 (it) * 2001-11-29 2003-05-29 Menarini Int Operations Lu Sa Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
US7183321B2 (en) * 2001-12-17 2007-02-27 Bristol-Myers Squibb Company Antidiabetic formulation and method
MXPA04007183A (es) * 2002-01-25 2006-03-06 Silanes Sa De Cv Lab Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2.
ES2627842T3 (es) * 2002-02-21 2017-07-31 Valeant Pharmaceuticals Luxembourg S.À.R.L. Formas de dosificación de liberación controlada
US20030187074A1 (en) * 2002-03-04 2003-10-02 Javed Hussain Oral compositions for treatment of diabetes
US20030219482A1 (en) * 2002-03-21 2003-11-27 Chaudhari Sunil Sudhakar Multiparticulate compositions for once-a-day administration
MXPA04009979A (es) 2002-04-09 2004-12-13 Flamel Tech Sa Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxicilina.
CN100553625C (zh) 2002-04-09 2009-10-28 弗拉梅技术公司 活性成分微囊的口服混悬液
AU2002356419A1 (en) 2002-06-17 2003-12-31 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
US7445796B2 (en) * 2002-08-19 2008-11-04 L. Perrigo Company Pharmaceutically active particles of a monomodal particle size distribution and method
CN1729005A (zh) * 2002-11-15 2006-02-01 兰贝克赛实验室有限公司 含双胍－磺酰脲类组合的药物剂型
FR2853831A1 (fr) * 2003-03-05 2004-10-22 Usv Ltd Forme posologique solide a usage oral de metformine et de glyburide et son procede de preparation
KR20050114275A (ko) * 2003-04-15 2005-12-05 추가이 세이야쿠 가부시키가이샤 당뇨병 치료제
US20060121108A1 (en) * 2004-12-02 2006-06-08 Prasad C K System and method for producing a directly compressible, high-potency formulation of metformin hydrochloride
CN100341495C (zh) * 2004-12-29 2007-10-10 三九医药股份有限公司 格列本脲固体分散体、口服组合物及其制备方法
KR100760430B1 (ko) * 2004-12-31 2007-10-04 한미약품 주식회사 당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
UY29445A1 (es) * 2005-03-30 2006-10-02 Generex Pharm Inc Composiciones para la transmisión transmucosa oral de la metformina
US8529537B2 (en) * 2005-08-05 2013-09-10 Kimberly-Clark Worldwide, Inc. Absorbent article with enclosures
MXPA05009633A (es) * 2005-09-08 2007-03-07 Silanes Sa De Cv Lab Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
ATE540681T1 (de) 2006-06-26 2012-01-15 Amgen Inc Verfahren zur behandlung von atherosklerose
WO2008062273A2 (en) * 2006-11-20 2008-05-29 Cadila Pharmaceuticals Limited Solid oral dosage form having antidiabetic drug combination
MY159203A (en) 2007-07-19 2016-12-30 Takeda Pharmaceuticals Co Solid preparation comprising alogliptin and metformin hydrochloride
MX348799B (es) 2007-07-26 2017-06-29 Amgen Inc Enzimas aciltransferasa de lecitina-colesterol, modificadas.
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
WO2011135106A1 (es) * 2010-04-26 2011-11-03 Smart Pharma Solutions, S.L Granulado altamente dispersable para la preparación de formulaciones de sustancias activas de altas dosis y procedimiento de obtención del mismo
RU2451506C1 (ru) 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
MX368200B (es) 2011-12-08 2019-09-24 Amgen Inc Proteinas de union al antigeno lecitin colesterol aciltransferasas humanas agonistas y su uso en terapia.
EP2790729A4 (en) * 2011-12-12 2015-08-12 Orbis Biosciences Inc PARTICULATE FORMULATIONS WITH DELAYED RELEASE
CN104127424A (zh) * 2014-07-30 2014-11-05 沈阳药科大学 格列本脲衍生物及其制备方法和应用
CN105030793A (zh) * 2015-08-25 2015-11-11 瑞阳制药有限公司 二甲双胍格列本脲胶囊及其制备方法
WO2019070109A1 (es) * 2017-10-03 2019-04-11 Infinite Clinical Research International, S.A. De C.V. Triconjugado para el tratamiento de diabetes mellitus
JP2023528726A (ja) 2020-04-01 2023-07-06 ハンジョウ ジョンメイ フアドン ファーマシューティカル シーオー．，エルティーディー． Ｇｌｐ１ｒアゴニスト遊離塩基の薬学的に許容される酸塩類およびその調製法
US12459954B2 (en) 2020-04-01 2025-11-04 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Crystalline form a of GLP-1 receptor agonist and preparation method therefor
KR102484756B1 (ko) * 2020-11-13 2023-01-06 한국생산기술연구원 용해성 증대 및 취급용이성을 갖는 파우더 배지의 과립화 방법
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE362704C (de) * 1921-08-09 1922-11-02 Naamlooze Vennootschap Interna Vorrichtung zum Senken einer Last, insbesondere eines Rettungsbootes
US3174901A (en) 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
DE2348334C2 (de) 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
US4060634A (en) * 1973-09-26 1977-11-29 Boehringer Mannheim G.M.B.H. Rapidly resorbable glibenclamide
US4916163A (en) 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
DE3833439A1 (de) 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
IE63463B1 (en) * 1989-02-06 1995-04-19 Zeneca Ltd Phenylsulphone derivatives
GB9016978D0 (en) * 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
DK36392D0 (da) 1992-03-19 1992-03-19 Novo Nordisk As Anvendelse af kemisk forbindelse
DE4323636A1 (de) 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
SI0996444T1 (sl) 1997-06-18 2007-08-31 Smithkline Beecham Plc Zdravljenje diabetesa s tiazolidindionom in metforminom
US6544564B1 (en) * 2001-11-27 2003-04-08 Michael Donald Farley Cytotoxic pharmaceutical composition

Also Published As

Publication number Publication date
AU2003261560A1 (en) 2005-05-26
RU2003126257A (ru) 2005-02-27
MA24930A1 (fr) 2000-04-01
AP2000001757A0 (en) 2000-03-31
EP1435240A3 (en) 2009-08-12
DK0974356T3 (da) 2003-10-27
JP2002520371A (ja) 2002-07-09
NZ503248A (en) 2002-09-27
TWI245632B (en) 2005-12-21
BR9906600A (pt) 2000-07-18
AU753604B2 (en) 2002-10-24
ID25784A (id) 2000-11-02
CN1146427C (zh) 2004-04-21
EP1011684A2 (en) 2000-06-28
ZA200001159B (en) 2001-05-31
CN1275082A (zh) 2000-11-29
EP2269613A2 (en) 2011-01-05
MY129552A (en) 2007-04-30
AP1450A (en) 2005-07-25
US6303146B1 (en) 2001-10-16
CA2303537C (en) 2005-12-06
DZ2846A1 (fr) 2003-12-01
KR100478347B1 (ko) 2005-03-23
KR20040053177A (ko) 2004-06-23
WO2000003742A3 (en) 2000-04-20
TW200303208A (en) 2003-09-01
KR20010030603A (ko) 2001-04-16
AR013052A1 (es) 2000-11-22
DE69818444T2 (de) 2004-05-06
CN1486698A (zh) 2004-04-07
ES2206868T3 (es) 2004-05-16
WO2000003742A2 (en) 2000-01-27
AR065970A2 (es) 2009-07-15
RU2226396C2 (ru) 2004-04-10
TW555560B (en) 2003-10-01
JP2003292443A (ja) 2003-10-15
EP2269613A3 (en) 2012-10-17
AU5417999A (en) 2000-02-07
CA2303537A1 (en) 2000-01-27
EP0974356B1 (en) 2003-09-24
RU2286788C2 (ru) 2006-11-10
EP1435240A2 (en) 2004-07-07
UY25611A1 (es) 2000-08-21
USRE38629E1 (en) 2004-10-19
DE69818444D1 (de) 2003-10-30
EP0974356A1 (en) 2000-01-26
PT974356E (pt) 2004-02-27
SI0974356T1 (en) 2003-12-31
OA11400A (en) 2004-04-08

Similar Documents

Publication Publication Date Title
DE69818444D1 (de) Tabletten enthaltend eine Kombination von Glibenclamid und Metformin
DE60038455D1 (de) Arzneimittel, umfassend eine kombination aus metformin und glibenclamide
NO961071D0 (no) Kjemiske forbindelser, deres fremstilling og anvendelse
FI961712A7 (fi) Kemiallisia pehmenninkoostumuksia ja sidosaineita sisältävä moninkertainen kasvopaperituote
ATE220635T1 (de) Aerosolspender und darin verwendete kartusche
FI940115L (fi) Nanokapseleita sisältävät farmaseuttiset seokset
EE9700341A (et) Aromaatsed ühendid ja neid sisaldavad farmatseutilised segud
DE69940450D1 (de) Photokatalysator eine Beschichtungszusammensetzung enthaltend
DE69232893D1 (de) Tintenvorratspatrone und Behälter dafür
DE69739162D1 (de) Eine mischung von phasenaustauschspeichermaterial und dielektrischem material enthaltendes verbundspeichermaterial
DE69519830D1 (de) Eine teilchenförmige strukturgebende Substanz enthaltendes festes Haarpflegemittel
DE59507427D1 (de) Mischkristalle und feste Lösungen von 1,4-Diketopyrrolopyrrolen
PL364885A1 (en) Pharmaceutical composition comprising a combination of metformin and glibenclamide
DK26389A (da) 1,4-disubstituerede piperidinyl-forbindelser og deres anvendelse
DE69500070D1 (de) Eine teilchenförmige strukturgebende Substanz enthaltendes festes Enthaarungsmittel
FI906360A7 (fi) Sulfonyyliurea- ja asetanilidirikkaruohomyrkkyjä sisältäviä suojausseoksia
BR9506868A (pt) Recipiente para produtos químicos
DE69505519D1 (de) Behälter-verschluss und abgabevorrichtung
DK155292D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK60593D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DE59006277D1 (de) Härtbare, ein Bismaleinimid und eine Propenylverbindung enthaltende Gemische.
DE69010049D1 (de) Koproduktion von Propandiamin und alkylierten Aminopropylaminen.
DE59306262D1 (de) N,N-Disubstituierte Sulfonamide und damit hergestelltes strahlungsempfindliches Gemisch
DK0809444T3 (da) Flydende sorbitol/mannitol/glycerin-blanding og præparater, som indeholder en sådan
BR8900655A (pt) Tampa para garrafas e assemelhados desmontaveis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0974356

Country of ref document: EP

RZN Patent revoked